Martín-Peña Almudena, Luque Márquez Rafael, Guerrero M José Marco, Espinosa Nuria, Blanco Yolanda, Ibeas José, Ríos-Villegas Ma José, Cisneros José Miguel
Department of Infectious Diseases, Clinical Microbiology and Preventive Medicine, University Hospital Virgen del Rocío, Sevilla, Spain.
J Vasc Access. 2012 Apr-Jun;13(2):239-45. doi: 10.5301/jva.5000034.
Catheter-related bloodstream infections (CRBSI) are common among patients undergoing long-term hemodialysis (HD) worldwide. The aim of this study was look into the incidence, epidemiology, and risk factors for CRBSI in four medical centers and Spanish dialysis facilities following a common protocol for insertion and management of tunneled hemodialysis catheters (THCs).
Prospective study including all THCs inserted from September-04 to October-05. Follow-up was from THC insertion to its withdrawal, onset of CRBSI or end of study. Data of all THCs, CRBSI episodes, and catheter complications were collected. A descriptive analysis of CRBSI incidence and etiology and multivariate Cox regression to identify risk factors for CRBSI was performed.
A total of 130 THCs in 123 patients were inserted. There were 34 879 catheter-days. Twelve CRBSI in 11 patients with a CRBSI rate of 0.34/1000 catheter-days were recorded. CRBSI was caused by gram-positive coccus in 91.7% of the cases. Vascular cause of renal disease (HR 25.5 CI95% 5.5-117.2), and a previous THC (HR 5.1 CI95% 1.3-19.1) were identified as risk factors for CRBSI. CRBSI were satisfactorily resolved in 83.3% of the cases. Overall mortality was 14.6% (18/123), in two cases (2/11) death occurred within 30 days after CRBSI onset.
Although some factors, such as vascular cause of renal disease and previous THC medical history, have been related to the onset of tunneled catheter-related bloodstream infections, the incidence of these bacteremia, mainly produced by gram-positive coccus, is low among hemodialysis patients and the mortality rate is not high.
在全球范围内,导管相关血流感染(CRBSI)在接受长期血液透析(HD)的患者中很常见。本研究的目的是按照隧道式血液透析导管(THC)插入和管理的通用方案,调查四个医疗中心和西班牙透析机构中CRBSI的发生率、流行病学及危险因素。
前瞻性研究,纳入2004年9月至2005年10月期间插入的所有THC。随访从THC插入至拔除、CRBSI发作或研究结束。收集所有THC、CRBSI发作及导管并发症的数据。对CRBSI发生率和病因进行描述性分析,并进行多变量Cox回归以确定CRBSI的危险因素。
共为123例患者插入了130根THC。导管使用天数为34879天。记录到11例患者发生12次CRBSI,CRBSI发生率为0.34/1000导管日。91.7%的病例中CRBSI由革兰氏阳性球菌引起。肾病的血管性病因(HR 25.5,95%CI 5.5 - 117.2)和既往使用THC(HR 5.1,95%CI 1.3 - 19.1)被确定为CRBSI的危险因素。83.3%的病例中CRBSI得到满意解决。总体死亡率为14.6%(18/123),2例(2/11)在CRBSI发作后30天内死亡。
尽管一些因素,如肾病的血管性病因和既往THC病史,与隧道式导管相关血流感染的发生有关,但这些主要由革兰氏阳性球菌引起的菌血症在血液透析患者中的发生率较低,死亡率也不高。